Institutional Biosafety Committee (IBC) definition

Institutional Biosafety Committee (IBC) means a committee set up by the Agency to carry out obligations under relevant provisions of these Regulations;
View Source

Examples of Institutional Biosafety Committee (IBC) in a sentence

  • If a clinical protocol has been reviewed by an Institutional Bio-safety Committee (IBC) or the NIH Recombinant DNA Advisory Committee (RAC), the Contractor must provide information about the initial and ongoing review and approval, if any.

  • All Biosafety Level 1 and 2 work must be approved by the SmartLabs Institutional Biosafety Committee (IBC).

  • Approval by the Institutional Biosafety Committee (IBC) on (Date).

  • If any research is to be performed, the foregoing FIU individual shall be responsible for ensuring that all FIU policies and procedures are followed before any research work is performed at FIU relating to this Agreement, including without limitation that any compliance approvals are in place from, as applicable, the Institutional Animal Care and Use Committee (IACUC), the Institutional Review Board (IRB) or the Institutional Biosafety Committee (IBC) prior to the commencement of the research.

  • I acknowledge that I have obtained appropriate approvals from the University of Virginia Institutional Biosafety Committee (IBC), and I assume all responsibility for informing and training personnel handling these biospecimens in the dangers and procedures for safe handling of human biospecimens.

  • Depending on the biosafety work, it may need to be reviewed either by the Cambridge Biosafety Committee (CBC) or an in-house Institutional Biosafety Committee (IBC).

  • This includes the requirements of the Standing Institutional Biosafety Committee (IBC) (See http://www4.od.nih.gov/oba/IBC/IBCindexpg.htm ).

  • All universal pandemic precautions will be followed and Institutional Biosafety Committee (IBC) approval will be in place for all testing and residual sample disposal.

  • Each organization involved in the conduct of NSF-supported recombinant DNA research subject to the Guidelines must have a standing Institutional Biosafety Committee (IBC) as specified in Section IV of the Guidelines.

  • All Biosafety Level 1 and 2 work must be approved by the Institutional Biosafety Committee (IBC).